Ardelyx (NASDAQ:ARDX), a biopharmaceutical company focused on developing first-in-class medicines, has announced its participation in four major investor conferences in September 2025:
Citi Biopharma Back to School Summit in Boston (Sept 3)
Cantor Global Healthcare Conference in New York (Sept 4)
Morgan Stanley 23rd Annual Global Healthcare Conference in New York (Sept 8)
H.C. Wainwright 27th Annual Global Investment Conference in New York (Sept 9)
Live webcasts of the fireside chats and presentations will be available on Ardelyx's investor relations website, with replays accessible for 30 days after each event.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.